Psoriasis-Clinical Features
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pdf/Bus Etat Des Lieux.Pdf Dermato-Allergol Bruxelles
1. w Volume 11, Number 2 April 2020 ISSN: 2081-9390 p. 113 - 223 DOI: 10.7241/ourd Issue online since Thursday April 02, 2020 Our Dermatology Online www.odermatol.com - Soraya Aouali, Imane Alouani, Hanane Ragragui, Nada Zizi, Siham Dikhaye A case of epithelioid angiosarcoma in a young man with chronic lymphedema - Iyda El Faqyr, Maria Dref, Sara Zahid, Jamila Oualla, Nabil Mansouri, Hanane Rais, Ouafa Hocar, Said Amal Syringocystadenoma papilliferum presented as an ulcerated nodule of the vulva in a patient with Neurofibromatosis type 1 - FMonisha Devi Selvakumari, Bittanakurike Narasappa Raghavendra, Anjan Kumar Patra A case of infantile Sweet’s syndrome - Anissa Zaouak, Leila Bouhajja, Houda Hammami, Samy Fenniche Penile annular lichen planus 2 / 2020 e-ISSN: 2081-9390 Editorial Pages DOI: 10.7241/ourd Quarterly published since 01/06/2010 years Our Dermatol Online www.odermatol.com Editor in Chief: Publisher: Piotr Brzeziński, MD Ph.D Our Dermatology Online Address: Address: ul. Braille’a 50B, 76200 Słupsk, Poland ul. Braille’a 50B, 76200 Słupsk, Poland tel. 48 692121516, fax. 48 598151829 tel. 48 692121516, fax. 48 598151829 e-mail: [email protected] e-mail: [email protected] Associate Editor: Ass. Prof. Viktoryia Kazlouskaya (USA) Indexed in: Universal Impact Factor for year 2012 is = 0.7319 system of opinion of scientific periodicals INDEX COPERNICUS (8,69) (Academic Search) EBSCO (Academic Search Premier) EBSCO MNiSW (kbn)-Ministerstwo Nauki i Szkolnictwa Wyższego (7.00) DOAJ (Directory of Open Acces Journals) Geneva Foundation -
HIV and the SKIN • Sudden Acute Exacerbations • Treatment Failure DR
2018/08/13 KEY FEATURES • Atypical presentation of common disorders • Severe or exaggerated presentations HIV AND THE SKIN • Sudden acute exacerbations • Treatment failure DR. FREDAH MALEKA DERMATOLOGY UNIVERSITY OF PRETORIA:KALAFONG VIRAL INFECTIONS EXANTHEM OF PRIMARY HIV INFECTION • Exanthem of primary HIV infection • Acute retroviral syndrome • Herpes simplex virus (HSV) • Morbilliform rash (exanthem) : 2-4 weeks after HIV exposure • Varicella Zoster virus (VZV) • Typically generalised • Molluscum contagiosum (Poxvirus) • Pronounced on face and trunk, sparing distal extremities • Human papillomavirus (HPV) • Associated : fever, lymphadenopathy, pharyngitis • Epstein Barr virus (EBV) • DDX: drug reaction • Cytomegalovirus (CMV) • other viral infections – EBV, Enteroviruses, Hepatitis B virus 1 2018/08/13 HERPES SIMPLEX VIRUS(HSV) • Vesicular eruption due to HSV 1&2 • Primary lesion: painful, grouped vesicles on an erythematous base • HIV: attacks are more frequent and severe • : chronic, non-healing, deep ulcers, with scarring and tissue destruction • CLUE: severe pain and recurrences • DDX: syphilis, chancroid, lymphogranuloma venereum • Tzanck smear, Histology, Viral culture HSV • Treatment: Acyclovir 400mg tds 7-10 days • Alternatives: Valacyclovir and Famciclovir • In setting of treatment failure, viral isolates tested for resistance against acyclovir • Alternative drugs: Foscarnet, Cidofovir • Chronic suppressive therapy ( >8 attacks per year) 2 2018/08/13 VARICELLA • Chickenpox • Presents with erythematous papules and umbilicated -
Experience with Molluscum Contagiosum and Associated Inflammatory Reactions in a Pediatric Dermatology Practice the Bump That Rashes
STUDY ONLINE FIRST Experience With Molluscum Contagiosum and Associated Inflammatory Reactions in a Pediatric Dermatology Practice The Bump That Rashes Emily M. Berger, MD; Seth J. Orlow, MD, PhD; Rishi R. Patel, MD; Julie V. Schaffer, MD Objective: To investigate the frequency, epidemiol- (50.6% vs 31.8%; PϽ.001). In patients with molluscum ogy, clinical features, and prognostic significance of in- dermatitis, numbers of MC lesions increased during the flamed molluscum contagiosum (MC) lesions, mollus- next 3 months in 23.4% of those treated with a topical cum dermatitis, reactive papular eruptions resembling corticosteroid and 33.3% of those not treated with a topi- Gianotti-Crosti syndrome, and atopic dermatitis in pa- cal corticosteroid, compared with 16.8% of patients with- tients with MC. out dermatitis. Patients with inflamed MC lesions were less likely to have an increased number of MC lesions Design: Retrospective medical chart review. over the next 3 months than patients without inflamed MC lesions or dermatitis (5.2% vs 18.4%; PϽ.03). The Setting: University-based pediatric dermatology practice. GCLRs were associated with inflamed MC lesion (PϽ.001), favored the elbows and knees, tended to be Patients: A total of 696 patients (mean age, 5.5 years) pruritic, and often heralded resolution of MC. Two pa- with molluscum. tients developed unilateral laterothoracic exanthem– like eruptions. Main Outcome Measures: Frequencies, characteris- tics, and associated features of inflammatory reactions Conclusions: Inflammatory reactions to MC, including to MC in patients with and without atopic dermatitis. the previously underrecognized GCLR, are common. Treat- ment of molluscum dermatitis can reduce spread of MC Results: Molluscum dermatitis, inflamed MC lesions, and via autoinoculation from scratching, whereas inflamed MC Gianotti-Crosti syndrome–like reactions (GCLRs) oc- lesions and GCLRs reflect cell-mediated immune re- curred in 270 (38.8%), 155 (22.3%), and 34 (4.9%) of sponses that may lead to viral clearance. -
Bronchiolitis Obliterans • Mycoplasma Induced Asthma/Wheezing • Resistant Mycoplasma Infection
CROSS CANADA ROUNDS - Long Case Mandeep Walia Clinical Fellow BC Children’s Hospital 21 June, 2018 Long Case History • 10 Y, Boy Feb 8th • Fever- low-moderate grade, rhinorrhea, cough (dry), mild sore throat • Nausea, non bilious vomiting Day 5- worsening cough -dry, sleep disturbance. • Walk in clinic- no wheeze. Prescribed ventolin. Minimal improvement Day 8- redness eyes, purulent discharge, blisters on lips, ulcers on tongue & buccal mucosa. Difficulty to swallow solids. History- cont • No headache, abnormal movements, visual or hearing loss • No chest pain/stridor/ • No diarrhoea. Vomiting stopped after D3 • No hematuria/dysuria. Feb 17 (D10)- BCCH ED : • concerns for extensive oral mucositis, new onset skin rash. Past Hx • Healthy pregnancy. No complications. • Born by SVD, no neonatal resuscitation/NICU stay. • Recurrent OM- evaluated by ENT-not required myringotomy tubes. • Mild eczema. Development - milestones normal Immunization- upto date Allergies- no known Treatment Hx- Tylenol/benadryl/Ventolin. No antibiotics/NSAIDS FHx- Caucasian descent. unremarkable. Social Hx- active in sports. No exposure to pets/smoke Physical exam • Weight- 37.9kg(77centile) Skin- • HR-96/min, RR-30/min , • pink papules, 2-3mm, central • SPO2 94% RA, T-39.2ᵒc, BP115/64 erosion, about 15-20 on trunk, • HEENT- upper & lower extremities. Sparing palms & soles. • B/L conjunctival injection, • purulent discharge MSK-no arthritis • • Lips, buccal mucosa , soft & hard Perianal skin, glans- normal palate-scattered vesicles & superficial erosions. No crusting (serous/hemorrhagic) • B/L ears-normal • No clubbing/lymphadenopathy Systemic Examination • Respiratory - tachyapnea. No retractions/indrawing. B/L air entry decreased. No wheeze/crackles. • CVS-S1 S2 normal. no murmur • PA- no HSM • Neurological - conscious. -
Viral Rashes: New and Old Peggy Vernon, RN, MA, CPNP, DCNP, FAANP C5
Viral Rashes: New and Old Peggy Vernon, RN, MA, CPNP, DCNP, FAANP C5 Disclosures •There are no financial relationships with commercial interests to disclose Viral Rashes: New and Old •Any unlabeled/unapproved uses of drugs or products referenced will be disclosed Peggy Vernon, RN, MA, CPNP, DCNP, FAANP ©Pvernon2021 ©Pvernon2021 Restrictions Objectives • Permission granted to the 2021 National Nurse • Identify a potential sequelae from hand, foot and Practitioner Symposium and its attendees mouth disease • Describe the pattern of distribution and lesion • All rights reserved. No part of this presentation may description of varicella be reproduced, stored, or transmitted in any form or • Identify a precursor of Henoch Schonlein Purpura by any means without written permission of the author •Contact Peggy Vernon at [email protected] ©Pvernon2021 ©Pvernon2021 Viral Exanthems Morbilliform Exanthems •Morbilliform • Measles (rubeola) •Papular-nodular • Rubella •Vesiculobullous • Roseola •Petechial • Erythema Infectiosum •Purpuric • Pityriasis Rosea • Infectious Mono ©Pvernon2021 ©Pvernon2021 1 Viral Rashes: New and Old Peggy Vernon, RN, MA, CPNP, DCNP, FAANP C5 Measles (Rubeola) MEASLES (RUBEOLA) • Prodrome: fever, malaise, cough, DIFFERENTIAL DIAGNOSIS conjunctivitis. Patient appears quite ill •Other morbilliform eruptions: Rubella, • Koplik’s spots: bluish-white erythema infectiosum, pityriasis rosea, elevations on buccal mucosa infectious mono • Exanthem: erythematous •DRUG maculopapular eruption, from scalp to forehead, posterior -
Drug Treatments in Psoriasis
Drug Treatments in Psoriasis Authors: David Gravette, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University; Morgan Luger, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University; Jay Moulton, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University; Wesley T. Lindsey, Pharm.D., Associate Clinical Professor of Pharmacy Practice, Drug Information and Learning Resource Center, Harrison School of Pharmacy, Auburn University Universal Activity #: 0178-0000-13-108-H01-P | 1.5 contact hours (.15 CEUs) Initial Release Date: November 29, 2013 | Expires: April 1, 2016 Alabama Pharmacy Association | 334.271.4222 | www.aparx.org | [email protected] SPRING 2014: CONTINUING EDUCATION |WWW.APARX.Org 1 EducatiONAL OBJECTIVES After the completion of this activity pharmacists will be able to: • Outline how to diagnose psoriasis. • Describe the different types of psoriasis. • Outline nonpharmacologic and pharmacologic treatments for psoriasis. • Describe research on new biologic drugs to be used for the treatment of psoriasis as well as alternative FDA uses for approved drugs. INTRODUCTION depression, and even alcoholism which decreases their quality of Psoriasis is a common immune modulated inflammatory life. It is uncertain why these diseases coincide with one another, disease affecting nearly 17 million people in North America and but it is hypothesized that the chronic inflammatory nature of Europe, which is approximately 2% of the population. The highest psoriasis is the underlying problem. frequencies occur in Caucasians -
Fundamentals of Dermatology Describing Rashes and Lesions
Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous, -
The Management of Psoriasis in Adults
DORSET MEDICINES ADVISORY GROUP THE MANAGEMENT OF PSORIASIS IN ADULTS Psoriasis is a common, genetically determined, inflammatory and proliferative disorder of the skin, the most characteristic lesions consisting of chronic, sharply demarcated, dull-red, scaly plaques, particularly on the extensor prominences and in the scalp. Self-care advice Many people's psoriasis symptoms start or become worse because of a certain event, known as a trigger. Common triggers include: • an injury to skin such as a cut, scrape, insect bite or sunburn (this is known as the Koebner response) • drinking excessive amounts of alcohol • smoking • stress • hormonal changes, particularly in women (for example during puberty and the menopause) • certain medicines such as lithium, some antimalarial medicines, anti-inflammatory medicines including ibuprofen, ACE inhibitors (used to treat high blood pressure) and beta blockers (used to treat congestive heart failure) • throat infections - in some people, usually children and young adults, a form of psoriasis called guttate psoriasis (which causes smaller pink patches, often without a lot of scaling) develops after a streptococcal throat infection, although most people who have streptococcal throat infections do not develop psoriasis • other immune disorders, such as HIV, which cause psoriasis to flare up or to appear for the first time Advice for patients can be found here Management pathway For people with any type of psoriasis assess: • disease severity • the impact of disease on physical, psychological and social wellbeing • whether they have psoriatic arthritis • the presence of comorbidities. • Consider using the Dermatology quality of life assessment: www.pcds.org.uk/p/quality-of-life Assess the severity and impact of any type of psoriasis: • at first presentation • before referral for specialist advice and at each referral point in the treatment pathway • to evaluate the efficacy of interventions. -
Viral Exanthem
Robert E. Kalb, M.D. Buffalo Medical Group, P.C. Phone: (716) 630-1102 Fax: (716) 633-6507 Department of Dermatology 325 Essjay Road Williamsville, New York 14221 Viral Exanthem What is a viral exanthem? An exanthem is a doctor’s word for a rash caused by an infectious organism. In this case, a viral exanthem is a rash caused by a virus. You may be familiar with some viral exanthems and you undoubtedly have had some yourself. One familiar viral exanthem is chickenpox. Other viral exanthems include measles and rubella, for which most people have been immunized against. While measles and rubella may sound unpleasant, the vast majority of the hundreds of other viral exanthems are harmless, yet they may cause short-term discomfort. Just as adults may get colds and experience uncomfortable, yet tolerable symptoms like a runny nose, sore throat, and coughing, viral exanthem’s symptoms include itching and redness and are also uncomfortable, but usually short-lived. They very rarely have emotional, developmental, or physical aftereffects. What are the symptoms of a viral exanthem? The most obvious symptom is the widespread rash, which may be anywhere over the body’s surface. Some viral exanthems have particular patterns that help us with diagnosing their cause. Other rashes may appear random. The rash may itch or it may not. Other symptoms may occur prior to or with the rash; fever, a tired achy feeling, irritability, loss of appetite, headache, and abdominal pain. What is the treatment for a viral exanthem? The treatment is symptom control and patience. You may benefit from an oral or topical antihistamine, or another topical anti-itch medication, as determined by the nature and extent of your problem. -
Pityriasis Rosea
BMJ 2015;351:h5233 doi: 10.1136/bmj.h5233 (Published 29 October 2015) Page 1 of 6 Practice PRACTICE PRACTICE POINTER Pityriasis rosea Samantha Eisman consultant dermatologist, Rodney Sinclair professor in dermatology Sinclair Dermatology, Melbourne, VIC, 3002, Australia Pityriasis rosea is an acute exanthem that may cause patients great anxiety but is self limiting and resolves within one to three How does pityriasis rosea present? months.1 It is a distinctive erythematous oval scaly eruption of Pityriasis rosea begins in 40-76% of patients with a single herald the trunk and limbs, with minimal constitutional symptoms. patch—an asymptomatic thin oval scaly plaque often on the What causes pityriasis rosea? trunk (fig 1⇓).7 Multiple herald patches may also occur.8 The patch is usually well demarcated, 2-4 cm in diameter, The cause of pityriasis rosea is uncertain but epidemiological erythematous, salmon coloured, or hyperpigmented. A fine (seasonal variation and clustering in communities) and clinical collarette of scale is attached to the periphery of the plaque with features suggest an infective agent. Light and electron its free edge extending internally. Within days to three weeks microscopy findings suggest infection with human herpesviruses 2 the second phase begins—the appearance of numerous smaller 6 and 7 (HHV-6/7). These viral antigens have been detected lesions, which are similar in configuration but occur along the in skin lesions by immunohistochemistry and their DNA has lines of cleavage of the trunk (Christmas tree pattern; figs 2⇓ been isolated from non-lesional skin, peripheral blood 3 and 3⇓). The rash typically lasts five weeks; it resolves within mononuclear cells, serum, and saliva samples. -
Wisconsin Childhood Communicable Diseases Wall Chart
WISCONSIN CHILDHOOD COMMUNICABLE DISEASES Disease Name Incubation Period Time Period When Person is Spread by Signs and Symptoms Criteria for Exclusion from School or Group Onsite Control and Prevention Measures Time from exposure to Contagious (AKA, causative agent) symptoms Cold sores Direct contact with open sores Fever, irritability, blisters in mouth, on gums, lips, 2-7 weeks after symptoms appear, virus Exclude until fever-free, child able to control drooling, (Herpes simplex virus) or saliva 2 days to 2 weeks conjunctivitis, keratitis shedding possible without symptoms blisters resolved Mononucleosis Person to person contact with Many months after infection; excretion None, unless illness prevents participation; no contact saliva 30-50 days Fever, sore throat, swollen lymph nodes, fatigue of virus can occur intermittently for life sports until spleen no longer enlarged (Mono, Epstein-Barr virus) For all diseases: Good handwashing and hygiene; avoid Mumps R/V Inhalation of respiratory Fever, swelling and tenderness of parotid glands, Exclude for 5 days after swelling onset (day of swelling kissing, sharing drinks, or utensils, use proper disinfection droplets, direct contact with 12-25 days; headache, earache, painful swollen testicles, From 2 days before to 5 days after onset is day zero); exclude susceptible* contacts from of surfaces and toys (Mumps virus) saliva of infected person usually 16-18 days abdominal pain with swollen ovaries swelling day 12 through day 25 after exposure Mumps: Provide immunization records for exposed -
Genital Psoriasis: a Systematic Literature Review on This Hidden Skin Disease
Acta Derm Venereol 2011 ; 91 ; 5-11 REVIEW ARTICLE Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease Kim A. P. MEEUWIS'-^ Joanne A. DE HULLU^ Leon F. A. G. MASSUGER^ Peter C. M. VAN DE KERKHOF' and Michelle M. VAN ROSSUM' Departments of 'Dermatology and 'Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands It is well known that the genital skin may be affected by of inverse psoriasis (synonym: flexural or intertriginous psoriasis. However, little is known about the prevalence psoriasis) (2, 4, 5). and clinical appearance of genital psoriasis, and genital The external genital skin is generally classified as skin is often neglected in the treatment of psoriatic pa- flexural skin, although it forms a unique area compri- tients. We performed an extensive systematic literature sing different structures and types of epithelium. The search for evidence-based data on genital psoriasis with epithelium covering the different structures of the vulva respect to epidemiology, aetiology, clinical and histopat- changes from stratified, keratinised squamous cell epit- hological presentation, diagnosis and treatment. Three helium on the outer parts to mucosa on the innermost bibliographical databases (PubMed, EMBASE and the regions (5, 6). Similarly, the male genital epithelium Cochrane Library) were used as data sources. Fifty-nine has a different pattern of keratinisation throughout the articles on genital psoriasis were included. The results genital area. The prepuce forms the anatomical cover- show that psoriasis frequently affects the genital skin, ing of the glans penis and is the junction between the but that evidence-based data with respect to the efficacy mucosal surface of the glans and coronal sulcus and the and safety of treatments for genital psoriasis are extre- keratinised squamous cell epithelium of the remaining mely limited.